Guilhem Bousquet

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Squamous Cell Carcinoma

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Targeted oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tai Van Nguyen, Diaddin Hamdan, Géraldine Falgarone, Kien Hung Do, Quang Van Le, Frédéric Pamoukdjian, Guilhem Bousquet
Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis. Targeted oncology (2024)
Diaddin Hamdan, Charlotte Gardair, Frederic Pamoukdjian, Marie-Noëlle Peraldi Gardin, Inès Nakouri, Christophe Leboeuf, Anne Janin, Céleste Lebbé, Maxime Battistella, Guilhem Bousquet
A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53. International journal of molecular sciences 25 (2) (2024)
Tai Van Nguyen, Diaddin Hamdan, Géraldine Falgarone, Kien Hung Do, Quang Van Le, Frédéric Pamoukdjian, Guilhem Bousquet
Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis. Targeted oncology 19 (4) (2024)
Diaddin Hamdan, Charlotte Gardair, Frederic Pamoukdjian, Marie-Noëlle Peraldi Gardin, Inès Nakouri, Christophe Leboeuf, Anne Janin, Céleste Lebbé, Maxime Battistella, Guilhem Bousquet
A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53. International journal of molecular sciences 25 (2) (2024)
Diaddin Hamdan, Charlotte Gardair, Frederic Pamoukdjian, Marie-Noëlle Peraldi Gardin, Inès Nakouri, Christophe Leboeuf, Anne Janin, Céleste Lebbé, Maxime Battistella, Guilhem Bousquet
A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53. International journal of molecular sciences 25 (2) (2024)
Justine Paris, Claire Wilhelm, Celeste Lebbé, Mohammed Elmallah, Frédéric Pamoukdjian, Audrey Héraud, Guillaume Gapihan, Aurore Van De Walle, Van Nhan Tran, Diaddin Hamdan, Clara Allayous, Maxime Battistella, Emmanuel Van Glabeke, Kah Wai Lim, Christophe Leboeuf, Sébastien Roger, Géraldine Falgarone, Anh Tuan Phan, Guilhem Bousquet
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers. Clinical and translational medicine 14 (3) (2024)
Justine Paris, Claire Wilhelm, Celeste Lebbé, Mohammed Elmallah, Frédéric Pamoukdjian, Audrey Héraud, Guillaume Gapihan, Aurore Van De Walle, Van Nhan Tran, Diaddin Hamdan, Clara Allayous, Maxime Battistella, Emmanuel Van Glabeke, Kah Wai Lim, Christophe Leboeuf, Sébastien Roger, Géraldine Falgarone, Anh Tuan Phan, Guilhem Bousquet
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers. Clinical and translational medicine 14 (3) (2024)
Tai Van Nguyen, Diaddin Hamdan, Géraldine Falgarone, Kien Hung Do, Quang Van Le, Frédéric Pamoukdjian, Guilhem Bousquet
Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis. Targeted oncology 19 (4) (2024)
Thuy Thi Nguyen, Diaddin Hamdan, Eurydice Angeli, Jean-Paul Feugeas, Quang Van Le, Frederic Pamoukdjian, Guilhem Bousquet
Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications. Cancers 15 (6) (2023)
Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review. International journal of molecular sciences 24 (4) (2023)
Diaddin Hamdan, Laetitia Marisa, Camille Tlemsani, Eurydice Angeli, Michael Soussan, Nicolas Derive, Pierre Laurent-Puig, Guilhem Bousquet
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? JCO precision oncology 7 (2023)
Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review. International journal of molecular sciences 24 (4) (2023)
Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review. International journal of molecular sciences 24 (4) (2023)
Eurydice Angeli, Guilhem Bousquet
A Boom in Nanotechnologies for a High Level of Precision Medicine. Cancers 15 (9) (2023)
Diaddin Hamdan, Laetitia Marisa, Camille Tlemsani, Eurydice Angeli, Michael Soussan, Nicolas Derive, Pierre Laurent-Puig, Guilhem Bousquet
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers? JCO precision oncology 7 (2023)
Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review. International journal of molecular sciences 24 (4) (2023)
Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review. International journal of molecular sciences 24 (4) (2023)
Eurydice Angeli, Guilhem Bousquet
A Boom in Nanotechnologies for a High Level of Precision Medicine. Cancers 15 (9) (2023)
Thuy Thi Nguyen, Diaddin Hamdan, Eurydice Angeli, Jean-Paul Feugeas, Quang Van Le, Frederic Pamoukdjian, Guilhem Bousquet
Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications. Cancers 15 (6) (2023)
Géraldine Falgarone, Guilhem Bousquet, Arnaud Wilmet, Albert Brizio, Valérie Faure, Celestin Guillouet, Franck Baudino, Isabelle Roque, Samuel Mayol, Frederic Pamoukdjian
A Teleconsultation Device, Consult Station, for Remote Primary Care: Multisite Prospective Cohort Study. Journal of medical Internet research 24 (5) (2022)
Tai Van Nguyen, Sabine Winterman, Margot Playe, Amélie Benbara, Laurent Zelek, Frederic Pamoukdjian, Guilhem Bousquet
Dose-Intense Cisplatin-Based Neoadjuvant Chemotherapy Increases Survival in Advanced Cervical Cancer: An Up-to-Date Meta-Analysis. Cancers 14 (3) (2022)
Géraldine Falgarone, Guilhem Bousquet, Arnaud Wilmet, Albert Brizio, Valérie Faure, Celestin Guillouet, Franck Baudino, Isabelle Roque, Samuel Mayol, Frederic Pamoukdjian
Correction: A Teleconsultation Device, Consult Station, for Remote Primary Care: Multisite Prospective Cohort Study. Journal of medical Internet research 24 (10) (2022)
Eurydice Angeli, Guilhem Bousquet
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood-Brain Barrier. Pharmaceutics 13 (9) (2021)
Justine Paris, Eurydice Angeli, Guilhem Bousquet
The Pharmacology of Xenobiotics after Intracerebro Spinal Fluid Administration: Implications for the Treatment of Brain Tumors. International journal of molecular sciences 22 (3) (2021)
Philippe Wind, Zoe Ap Thomas, Marie Laurent, Thomas Aparicio, Matthieu Siebert, Etienne Audureau, Elena Paillaud, Guilhem Bousquet, Frédéric Pamoukdjian
The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers 14 (1) (2021)
Fiamma Burgassi, Elena Paillaud, Johanne Poisson, Guilhem Bousquet, Frédéric Pamoukdjian
Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers 13 (22) (2021)
Eurydice Angeli, Thuy T Nguyen, Anne Janin, Guilhem Bousquet
How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases. International journal of molecular sciences 21 (1) (2019)